Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer limited - ziprasidone hydrochloride monohydrate - capsules hard - 80 milligram - antipsychotics

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

viatris healthcare (pty) ltd - capsules - see ingredients - each capsule contains ziprasidone hydrochloride equivalent to ziprasidone 20,0 mg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

viatris healthcare (pty) ltd - capsules - see ingredients - each capsule contains ziprasidone hydrochloride monohydrate equivalent to ziprasidone 40,0 mg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

viatris healthcare (pty) ltd - capsules - see ingredients - each capsule contains ziprasidone hydrochloride monohydrate equivalent to ziprasidone 60,0 mg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

viatris healthcare (pty) ltd - capsules - see ingredients - each capsule contains ziprasidone hydrochloride monohydrate equivalent to ziprasidone 80,0 mg

United States - English - NLM (National Library of Medicine)

roerig - ziprasidone hydrochloride (unii: 216x081oru) (ziprasidone - unii:6uka5vej6x) - ziprasidone 20 mg - geodon is indicated for the treatment of schizophrenia, as monotherapy for the acute treatment of bipolar manic or mixed episodes, and as an adjunct to lithium or valproate for the maintenance treatment of bipolar disorder. geodon intramuscular is indicated for acute agitation in schizophrenic patients. when deciding among the alternative treatments available for the condition needing treatment, the prescriber should consider the finding of ziprasidone's greater capacity to prolong the qt/qtc interval compared to several other antipsychotic drugs [see warnings and precautions (5.3)] . prolongation of the qtc interval is associated in some other drugs with the ability to cause torsade de pointes-type arrhythmia, a potentially fatal polymorphic ventricular tachycardia, and sudden death. in many cases this would lead to the conclusion that other drugs should be tried first. whether ziprasidone will cause torsade de pointes or increase the rate of sudden death is not yet known [see warnings and precautions (5.3)]

United States - English - NLM (National Library of Medicine)

remedyrepack inc. - ziprasidone hydrochloride (unii: 216x081oru) (ziprasidone - unii:6uka5vej6x) - geodon is indicated for the treatment of schizophrenia, as monotherapy for the acute treatment of bipolar manic or mixed episodes, and as an adjunct to lithium or valproate for the maintenance treatment of bipolar disorder. geodon intramuscular is indicated for acute agitation in schizophrenic patients. when deciding among the alternative treatments available for the condition needing treatment, the prescriber should consider the finding of ziprasidone's greater capacity to prolong the qt/qtc interval compared to several other antipsychotic drugs [see warnings and precautions (5.3)] . prolongation of the qtc interval is associated in some other drugs with the ability to cause torsade de pointes-type arrhythmia, a potentially fatal polymorphic ventricular tachycardia, and sudden death. in many cases this would lead to the conclusion that other drugs should be tried first. whether ziprasidone will cause torsade de pointes or increase the rate of sudden death is not yet known [see warnings and precautions (5.3)

Singapore - English - HSA (Health Sciences Authority)

viatris private limited - tolterodine tartrate - capsule, extended release - 2 mg - tolterodine tartrate 2 mg

Singapore - English - HSA (Health Sciences Authority)

viatris private limited - tolterodine tartrate - capsule, extended release - 4 mg - tolterodine tartrate 4 mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

zentiva pharma uk ltd - tolterodine tartrate - modified-release capsule - 4mg